IQVIA (NYSE:IQV) Shares Gap Down – Time to Sell?

IQVIA Holdings Inc. (NYSE:IQV) gapped down prior to trading on Tuesday . The stock had previously closed at $204.64, but opened at $198.98. IQVIA shares last traded at $199.37, with a volume of 273,028 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Leerink Partners reaffirmed an “outperform” rating and issued a $248.00 price objective (down from $260.00) on shares of IQVIA in a research note on Tuesday, November 19th. Bank of America lowered their target price on IQVIA from $255.00 to $235.00 and set a “buy” rating for the company in a research note on Friday, December 13th. Royal Bank of Canada reissued an “outperform” rating and issued a $270.00 target price on shares of IQVIA in a report on Wednesday, December 11th. BTIG Research reduced their target price on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, StockNews.com downgraded IQVIA from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, IQVIA currently has an average rating of “Moderate Buy” and a consensus price target of $255.82.

IQVIA Price Performance

The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The business has a 50-day moving average price of $201.43 and a two-hundred day moving average price of $221.61. The firm has a market capitalization of $35.23 billion, a price-to-earnings ratio of 25.47, a PEG ratio of 2.09 and a beta of 1.48.

Institutional Trading of IQVIA

Several large investors have recently added to or reduced their stakes in IQV. Massachusetts Financial Services Co. MA increased its position in IQVIA by 1.9% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 140,039 shares of the medical research company’s stock valued at $29,610,000 after acquiring an additional 2,576 shares during the period. Dimensional Fund Advisors LP boosted its stake in IQVIA by 5.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,197,084 shares of the medical research company’s stock valued at $253,125,000 after purchasing an additional 60,827 shares in the last quarter. Citizens Financial Group Inc. RI bought a new position in IQVIA during the 2nd quarter valued at $435,000. Primecap Management Co. CA boosted its stake in shares of IQVIA by 0.4% during the 2nd quarter. Primecap Management Co. CA now owns 325,176 shares of the medical research company’s stock worth $68,755,000 after acquiring an additional 1,220 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new stake in shares of IQVIA during the 2nd quarter worth $5,038,000. 89.62% of the stock is currently owned by institutional investors and hedge funds.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.